These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12043072)
1. [The effectiveness of HAART. Good planning assures long-term success]. Manegold C MMW Fortschr Med; 2002 Apr; 144 Suppl 1():4-6. PubMed ID: 12043072 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro. Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762 [TBL] [Abstract][Full Text] [Related]
3. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485 [TBL] [Abstract][Full Text] [Related]
4. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275 [TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV. Corzillius M; Mühlberger N; Sroczynski G; Jaeger H; Wasem J; Siebert U Antivir Ther; 2004 Feb; 9(1):27-36. PubMed ID: 15040534 [TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
7. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689 [TBL] [Abstract][Full Text] [Related]
8. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Viani RM; Araneta MR; Deville JG; Spector SA Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789 [TBL] [Abstract][Full Text] [Related]
10. Recent developments in HIV treatment, Part 2. Boyle BA AIDS Read; 2005 Jun; 15(6):277-9, 284. PubMed ID: 15962449 [No Abstract] [Full Text] [Related]
11. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Hoffmann C; Chow KU; Wolf E; Faetkenheuer G; Stellbrink HJ; van Lunzen J; Jaeger H; Stoehr A; Plettenberg A; Wasmuth JC; Rockstroh J; Mosthaf F; Horst HA; Brodt HR Br J Haematol; 2004 May; 125(4):455-62. PubMed ID: 15142115 [TBL] [Abstract][Full Text] [Related]
12. Challenges of the unmet needs in the treatment-experienced patient. Montaner JS AIDS Read; 2003 Jun; 13(6 Suppl):S5-9. PubMed ID: 12838741 [TBL] [Abstract][Full Text] [Related]
13. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408 [TBL] [Abstract][Full Text] [Related]
14. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country. Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254 [TBL] [Abstract][Full Text] [Related]
15. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
16. Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected population. Lohse N; Ladefoged K; Pedersen L; Jensen-Fangel S; Sørensen HT; Obel N Scand J Infect Dis; 2004; 36(10):738-42. PubMed ID: 15513400 [TBL] [Abstract][Full Text] [Related]
17. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Kaufmann GR; Khanna N; Weber R; Perrin L; Furrer H; Cavassini M; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Hirschel B; Battegay M; Antivir Ther; 2004 Apr; 9(2):263-74. PubMed ID: 15134189 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy in previously untreated adults infected with the human immunodeficiency virus type I: established and potential determinants of virological outcome. Lowe SH; Prins JM; Lange JM Neth J Med; 2004 Dec; 62(11):424-40. PubMed ID: 15685893 [TBL] [Abstract][Full Text] [Related]
19. [Salvage therapy in HIV infection]. Salzberger B MMW Fortschr Med; 2004 Apr; 146 Spec No 1():52, 54-5, 57. PubMed ID: 15373050 [TBL] [Abstract][Full Text] [Related]
20. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review]. Vladusić I; Krajinović V; Begovac J Acta Med Croatica; 2006 Jun; 60(3):259-63. PubMed ID: 16933840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]